During the past decade, Valley Medical Primary Care conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 10 clinical trials were completed, i.e. on average, 111.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 8 clinical trials were completed. i.e. 266.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Valley Medical Primary Care" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "AstraZeneca" with 2 trials sponsored, "Avid Radiopharmaceuticals" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Valley Medical Primary Care" #1 collaborator was "AbCellera Biologics Inc." with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Shanghai Junshi Bioscience Co., Ltd." with 2 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "HealthCore-NERI" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Valley Medical Primary Care" are "Alzheimer's Disease" (4 trials), "Alzheimer Disease" (2 trials), "COVID-19" (2 trials), "Alzheimer´s Disease" (1 trials) and "Diabetes Type 2" (1 trials). Many other conditions were trialed in "Valley Medical Primary Care" in a lesser frequency.

Most popular intervention types in "Valley Medical Primary Care" are "Drug" (12 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Bamlanivimab" (2 trials), "Etesevimab" (2 trials), "Lanabecestat" (2 trials) and "70% insulin aspart protamine suspension and 30% insulin aspart injection (rDNA origin)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Valley Medical Primary Care" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Valley Medical Primary Care". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Valley Medical Primary Care, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Valley Medical Primary Care, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".